Andrew S Boyer Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Andrew S Boyer is Executive Vice President of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 290,106 shares of AMRX, which is worth approximately $2.4 Million. The most recent transaction as insider was on Jun 30, 2022, when has been sold 23,094 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 290K

13.03% 3M change

9.17% 12M change

Total Value Held $2.4 Million

ANDREW S BOYER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2022	BUY Exercise of conversion of derivative security	-	23,094 Added 9.51%	219,678 Class A Common Stock
May 07 2022	SELL Payment of exercise price or tax liability	$28,400 $3.4 p/Share	8,353 Reduced 4.08%	196,584 Class A Common Stock
May 07 2022	BUY Exercise of conversion of derivative security	-	16,656 Added 7.52%	204,937 Class A Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$97,566 $4.45 p/Share	21,925 Reduced 10.43%	188,281 Class A Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	43,716 Added 17.65%	204,014 Class A Common Stock
Feb 27 2022	SELL Payment of exercise price or tax liability	$75,432 $4.59 p/Share	16,434 Reduced 8.98%	166,490 Class A Common Stock
Feb 27 2022	BUY Exercise of conversion of derivative security	-	31,662 Added 14.75%	182,924 Class A Common Stock
Jun 30 2021	SELL Payment of exercise price or tax liability	$59,305 $5.12 p/Share	11,583 Reduced 7.11%	151,262 Class A Common Stock
Jun 30 2021	BUY Exercise of conversion of derivative security	-	23,095 Added 12.42%	162,845 Class A Common Stock
May 07 2021	SELL Payment of exercise price or tax liability	$43,436 $5.2 p/Share	8,353 Reduced 5.64%	139,750 Class A Common Stock
May 07 2021	BUY Exercise of conversion of derivative security	-	16,655 Added 10.11%	148,103 Class A Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$32,075 $5.18 p/Share	6,192 Reduced 4.5%	131,448 Class A Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	-	12,346 Added 8.23%	137,640 Class A Common Stock
Feb 27 2021	SELL Payment of exercise price or tax liability	$87,862 $5.39 p/Share	16,301 Reduced 11.51%	125,294 Class A Common Stock
Feb 27 2021	BUY Exercise of conversion of derivative security	-	31,662 Added 18.27%	141,595 Class A Common Stock

ASB

Andrew S Boyer

Executive Vice President

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account